更正 "撤回"。

IF 3.2 4区生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Biotechnology and applied biochemistry Pub Date : 2024-05-20 DOI:10.1002/bab.2608

{"title":"更正 \"撤回\"。","authors":"","doi":"10.1002/bab.2608","DOIUrl":null,"url":null,"abstract":"Retraction Statement: Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosisCui, X., Liu, Y., Wang, B., Xian, G., Liu, X., Tian, X. and Qin, C. (2015), Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Biotechnology and Applied Biochemistry, 62: 861−867. https://doi.org/10.1002/bab.1326We apologize for errors in the retraction text wording which should have read as follows:","PeriodicalId":9274,"journal":{"name":"Biotechnology and applied biochemistry","volume":"71 3","pages":"693"},"PeriodicalIF":3.2000,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bab.2608","citationCount":"0","resultStr":"{\"title\":\"Correction to “Retraction”\",\"authors\":\"\",\"doi\":\"10.1002/bab.2608\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Retraction Statement: Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosisCui, X., Liu, Y., Wang, B., Xian, G., Liu, X., Tian, X. and Qin, C. (2015), Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Biotechnology and Applied Biochemistry, 62: 861−867. https://doi.org/10.1002/bab.1326We apologize for errors in the retraction text wording which should have read as follows:\",\"PeriodicalId\":9274,\"journal\":{\"name\":\"Biotechnology and applied biochemistry\",\"volume\":\"71 3\",\"pages\":\"693\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bab.2608\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology and applied biochemistry\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bab.2608\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology and applied biochemistry","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bab.2608","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

撤稿声明：通过RNAi敲除GPR137抑制胰腺癌细胞生长并诱导凋亡Cui, X., Liu, Y., Wang, B., Xian, G., Liu, X., Tian, X. and Qin, C. (2015), Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis.生物技术与应用生物化学》，62: 861-867。https://doi.org/10.1002/bab.1326We，对撤稿文本措辞中的错误表示歉意，其内容应如下：

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction to “Retraction”

Retraction Statement: Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis

Cui, X., Liu, Y., Wang, B., Xian, G., Liu, X., Tian, X. and Qin, C. (2015), Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Biotechnology and Applied Biochemistry, 62: 861−867. https://doi.org/10.1002/bab.1326

We apologize for errors in the retraction text wording which should have read as follows:

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biotechnology and applied biochemistry 工程技术-生化与分子生物学

CiteScore

6.00

自引率

7.10%

发文量

117

审稿时长

3 months

期刊介绍： Published since 1979, Biotechnology and Applied Biochemistry is dedicated to the rapid publication of high quality, significant research at the interface between life sciences and their technological exploitation. The Editors will consider papers for publication based on their novelty and impact as well as their contribution to the advancement of medical biotechnology and industrial biotechnology, covering cutting-edge research in synthetic biology, systems biology, metabolic engineering, bioengineering, biomaterials, biosensing, and nano-biotechnology.